FDA Issues More Guidance on Real-World Evidence, Delving Into Noninterventional Studies

The FDA has published further draft guidance on real-world evidence (RWE), this time outlining regulatory considerations for noninterventional studies that use real-world data (RWD).
Source: Drug Industry Daily